A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to investigate the safety, tolerability, and efficacy
of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma.